Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||lung non-small cell carcinoma||not applicable||BPI-9016M||Phase I||Actionable||In a Phase I trial, BPI-9016M treatment was well-tolerated in patients with non-small cell lung cancer who had progressed on prior therapy (n=20), and of nineteen evaluable patients, one patient had a partial response and 10 patients experienced stable disease (PMID: 31948451; NCT02478866).||31948451|